ciglitazone and 4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid

ciglitazone has been researched along with 4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bissonnette, RP; Chen, YE; Leander, M; Major, EO; Royal, W1

Other Studies

1 other study(ies) available for ciglitazone and 4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid

ArticleYear
Nuclear receptor activation and interaction with morphine.
    Journal of neuroimmunology, 2004, Volume: 157, Issue:1-2

    Topics: Astrocytes; Benzoates; Cell Line; Cell Line, Tumor; Drug Interactions; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Gene Expression Regulation; Humans; Lymphoma; Morphine; Naloxone; Narcotic Antagonists; Narcotics; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Phytohemagglutinins; Retinoid X Receptors; Retinoids; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tetrahydronaphthalenes; Thiazolidinediones; Tumor Necrosis Factor-alpha

2004
chemdatabank.com